Cargando…

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study

INTRODUCTION: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guidelines for PAH recommend multiple investigations, including annual echocardiography, which together have low specificity and may not be cost-effective. We sought to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Vivek, Stevens, Wendy, Prior, David, Youssef, Peter, Liew, Danny, Gabbay, Eli, Roddy, Janet, Walker, Jennifer G, Zochling, Jane, Sahhar, Joanne, Nash, Peter, Lester, Susan, Rischmueller, Maureen, Proudman, Susanna M, Nikpour, Mandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978999/
https://www.ncbi.nlm.nih.gov/pubmed/24246100
http://dx.doi.org/10.1186/ar4383
_version_ 1782310667591614464
author Thakkar, Vivek
Stevens, Wendy
Prior, David
Youssef, Peter
Liew, Danny
Gabbay, Eli
Roddy, Janet
Walker, Jennifer G
Zochling, Jane
Sahhar, Joanne
Nash, Peter
Lester, Susan
Rischmueller, Maureen
Proudman, Susanna M
Nikpour, Mandana
author_facet Thakkar, Vivek
Stevens, Wendy
Prior, David
Youssef, Peter
Liew, Danny
Gabbay, Eli
Roddy, Janet
Walker, Jennifer G
Zochling, Jane
Sahhar, Joanne
Nash, Peter
Lester, Susan
Rischmueller, Maureen
Proudman, Susanna M
Nikpour, Mandana
author_sort Thakkar, Vivek
collection PubMed
description INTRODUCTION: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guidelines for PAH recommend multiple investigations, including annual echocardiography, which together have low specificity and may not be cost-effective. We sought to evaluate the predictive accuracy of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) in combination with pulmonary function tests (PFT) (‘proposed’ algorithm) in a screening algorithm for SSc-PAH. METHODS: We evaluated our proposed algorithm (PFT with NT-proBNP) on 49 consecutive SSc patients with suspected pulmonary hypertension undergoing right heart catherisation (RHC). The predictive accuracy of the proposed algorithm was compared with existing screening recommendations, and is presented as sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). RESULTS: Overall, 27 patients were found to have pulmonary hypertension (PH) at RHC, while 22 had no PH. The sensitivity, specificity, PPV and NPV of the proposed algorithm for PAH was 94.1%, 54.5%, 61.5% and 92.3%, respectively; current European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines achieved a sensitivity, specificity, PPV and NPV of 94.1%, 31.8%, 51.6% and 87.5%, respectively. In an alternate case scenario analysis, estimating a PAH prevalence of 10%, the proposed algorithm achieved a sensitivity, specificity, PPV and NPV for PAH of 94.1%, 54.5%, 18.7% and 98.8%, respectively. CONCLUSIONS: The combination of NT-proBNP with PFT is a sensitive, yet simple and non-invasive, screening strategy for SSc-PAH. Patients with a positive screening result can be referred for echocardiography, and further confirmatory testing for PAH. In this way, it may be possible to shift the burden of routine screening away from echocardiography. The findings of this study should be confirmed in larger studies.
format Online
Article
Text
id pubmed-3978999
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39789992014-04-09 The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study Thakkar, Vivek Stevens, Wendy Prior, David Youssef, Peter Liew, Danny Gabbay, Eli Roddy, Janet Walker, Jennifer G Zochling, Jane Sahhar, Joanne Nash, Peter Lester, Susan Rischmueller, Maureen Proudman, Susanna M Nikpour, Mandana Arthritis Res Ther Research Article INTRODUCTION: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosis (SSc). Screening guidelines for PAH recommend multiple investigations, including annual echocardiography, which together have low specificity and may not be cost-effective. We sought to evaluate the predictive accuracy of serum N-terminal pro-brain natriuretic peptide (NT-proBNP) in combination with pulmonary function tests (PFT) (‘proposed’ algorithm) in a screening algorithm for SSc-PAH. METHODS: We evaluated our proposed algorithm (PFT with NT-proBNP) on 49 consecutive SSc patients with suspected pulmonary hypertension undergoing right heart catherisation (RHC). The predictive accuracy of the proposed algorithm was compared with existing screening recommendations, and is presented as sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). RESULTS: Overall, 27 patients were found to have pulmonary hypertension (PH) at RHC, while 22 had no PH. The sensitivity, specificity, PPV and NPV of the proposed algorithm for PAH was 94.1%, 54.5%, 61.5% and 92.3%, respectively; current European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines achieved a sensitivity, specificity, PPV and NPV of 94.1%, 31.8%, 51.6% and 87.5%, respectively. In an alternate case scenario analysis, estimating a PAH prevalence of 10%, the proposed algorithm achieved a sensitivity, specificity, PPV and NPV for PAH of 94.1%, 54.5%, 18.7% and 98.8%, respectively. CONCLUSIONS: The combination of NT-proBNP with PFT is a sensitive, yet simple and non-invasive, screening strategy for SSc-PAH. Patients with a positive screening result can be referred for echocardiography, and further confirmatory testing for PAH. In this way, it may be possible to shift the burden of routine screening away from echocardiography. The findings of this study should be confirmed in larger studies. BioMed Central 2013 2013-11-19 /pmc/articles/PMC3978999/ /pubmed/24246100 http://dx.doi.org/10.1186/ar4383 Text en Copyright © 2013 Thakkar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Thakkar, Vivek
Stevens, Wendy
Prior, David
Youssef, Peter
Liew, Danny
Gabbay, Eli
Roddy, Janet
Walker, Jennifer G
Zochling, Jane
Sahhar, Joanne
Nash, Peter
Lester, Susan
Rischmueller, Maureen
Proudman, Susanna M
Nikpour, Mandana
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title_full The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title_fullStr The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title_full_unstemmed The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title_short The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
title_sort inclusion of n-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978999/
https://www.ncbi.nlm.nih.gov/pubmed/24246100
http://dx.doi.org/10.1186/ar4383
work_keys_str_mv AT thakkarvivek theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT stevenswendy theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT priordavid theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT youssefpeter theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT liewdanny theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT gabbayeli theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT roddyjanet theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT walkerjenniferg theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT zochlingjane theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT sahharjoanne theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT nashpeter theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT lestersusan theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT rischmuellermaureen theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT proudmansusannam theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT nikpourmandana theinclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT thakkarvivek inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT stevenswendy inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT priordavid inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT youssefpeter inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT liewdanny inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT gabbayeli inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT roddyjanet inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT walkerjenniferg inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT zochlingjane inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT sahharjoanne inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT nashpeter inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT lestersusan inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT rischmuellermaureen inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT proudmansusannam inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy
AT nikpourmandana inclusionofnterminalprobrainnatriureticpeptideinasensitivescreeningstrategyforsystemicsclerosisrelatedpulmonaryarterialhypertensionacohortstudy